tiprankstipranks
Lipella Pharmaceuticals, Inc. (LIPO)
NASDAQ:LIPO
US Market

Lipella Pharmaceuticals, Inc. (LIPO) Financial Statements

Compare
110 Followers

Lipella Pharmaceuticals, Inc. Financial Overview

Lipella Pharmaceuticals, Inc.'s market cap is currently $4.13M. The company's EPS TTM is $-4.495; its P/E ratio is ―; Lipella Pharmaceuticals, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 449.62K$ 184.16K$ 259.35K$ 961.68K$ 694.75K
Gross Profit$ -2.59M$ -2.36M$ -1.20M$ -14.28K$ 11.86K
Operating Income$ -4.75M$ -2.59M$ -1.92M$ -56.86K$ -53.79K
EBITDA$ -4.61M$ -2.59M$ 0.00$ -53.69K$ 334.00
Net Income$ -4.62M$ -2.60M$ -1.87M$ -66.45K$ -61.85K
Balance Sheet
Cash & Short-Term Investments$ 3.29M$ 5.12M$ 1.71M$ 606.74K$ 26.00K
Total Assets$ 3.58M$ 5.95M$ 2.01M$ 955.02K$ 118.92K
Total Debt$ 136.59K$ 429.52K$ 282.96K$ 388.91K$ 100.00K
Net Debt$ -3.16M$ -4.69M$ -1.13M$ -217.82K$ 74.00K
Total Liabilities$ 432.73K$ 1.27M$ 589.34K$ 491.70K$ 237.26K
Stockholders' Equity$ 3.14M$ 4.68M$ 1.42M$ 463.32K$ -118.34K
Cash Flow
Free Cash Flow$ -3.16M$ -1.83M$ -989.27K$ -28.58K$ -39.12K
Operating Cash Flow$ -3.15M$ -1.83M$ -989.27K$ -28.58K$ -39.12K
Investing Cash Flow$ -14.43K$ 300.55K$ -300.55K$ 0.00$ 0.00
Financing Cash Flow$ 1.34M$ 5.24M$ 2.10M$ 609.31K$ 25.00K
Currency in USD

Lipella Pharmaceuticals, Inc. Earnings and Revenue History

Lipella Pharmaceuticals, Inc. Debt to Assets

Lipella Pharmaceuticals, Inc. Cash Flow

Lipella Pharmaceuticals, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis